Browsing by Author Fisher, Richard

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)Citation
2017Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04)Ansari, Nabila; Solomon, Michael; Ackland, Stephen; Burmeister, Bryan; Fisher, Richard; Heriot, Alexander; Joseph, David; Mackay, John; McClure, Bev; McLachlan, Sue-Anne; Ngan, Samuel; Medicine; Central Clinical School: SurgeryAcute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04), Annals of Surgery, vol.265, 5, 2017,pp 882-888
2015Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trialHong, Angela; Scolyer, Richard; Shannon, Kerwin; Thompson, John; Ainslie, Jill; Babington, Scott; Burmeister, Bryan H.; Carruthers, Scott; Coventry, Brendon; Di Iulio, Juliana; Duprat, Joao; Fisher, Richard; Henderson, M; Hoekstra, Harald J.; Smithers, B. Mark; Central Clinical School: Medicine; Central Clinical School: Pathology; Medicine; Central Clinical School: SurgeryAdjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial, Lancet Oncology, vol.16, 9, 2015,pp 1049-1060
2012Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trialHong, Angela; Scolyer, Richard; Shannon, Kerwin; Thompson, John; Ainslie, Jill; Babington, Scott; Burmeister, Bryan H.; Carruthers, Scott; Coventry, Brendon J; Dilulio, J.; Duprat, Joao; Fisher, Richard; Henderson, Michael A.; Hoekstra, Harald J.; Smithers, Bernard Mark; Central Clinical School: Medicine; Central Clinical School: Pathology; Medicine; Central Clinical School: SurgeryAdjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial, Lancet Oncology, vol.13, 6, 2012,pp 589-597
2016The impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04)Solomon, Michael; Ackland, Stephen; Burmeister, Bryan H.; Fisher, Richard; Goldstein, David; Leong, Trevor; Mackay, John; McClure, Bev; McKendrick, Joseph; McLachlan, Sue Anne; Ngan, S. Y.; Zalcberg, John; Central Clinical School: SurgeryThe impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04), European Journal of Cancer, vol.55, N/A, 2016,pp 15-26
2014A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy - Adjuvant Versus Early Salvage (RAVES) trialWoo, Henry; Davis, Ian D; Duchesne, Gillian; et al, .; Fisher, Richard; Fraser-Browne, Carol; Frydenberg, Mark; Haworth, Annette; Jose, Chakiath; Joseph, David; Pearse, Maria; SAHCS: SurgeryA Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy - Adjuvant Versus Early Salvage (RAVES) trial, BJU International, vol.113, Supplement 2, 2014,pp 7-12
2012Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04Solomon, Michael; Ackland, Stephen; Burmeister, Bryan H.; Fisher, Richard; Goldstein, D; Hartopeanu, Chris; Joseph, David; Leong, T.; Mackay, John; McClure, Bev; McKendrick, J; McLachlan, Sue Anne; Ngan, S. Y.; Schache, David; Zalcberg, John; Central Clinical School: SurgeryRandomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04, Journal of Clinical Oncology, vol.30, 31, 2012,pp 3827-3833
2005Tirapazamine, Cisplatin, and Radiation Versus Fluorouracil, Cisplatin, and Radiation in Patients With Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02)Jackson, Michael; Corry, June; Denham, Jim; et al, various; Fisher, Richard; Kenny, Lizbeth Kenny; Macann, Andrew; Penniment, Michael; Peters, Lester; Poulsen, Michael; Rischin, D.; Central Clinical School: MedicineTirapazamine, Cisplatin, and Radiation Versus Fluorouracil, Cisplatin, and Radiation in Patients With Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02), Journal of Clinical Oncology, vol.23,(1),2005,pp 79-87
2017Values and ethical judgments: The adequacy of students as surrogates for professional accountantsWaldron, Marilyn; Fisher, Richard; AccountingValues and ethical judgments: The adequacy of students as surrogates for professional accountants, Meditari Accountancy Research, vol.25, 1, 2017,pp 37-64